HOMEVULNERABILITIESCVE-2017-17674
CRITICAL

CVE-2017-17674

CWE-918Published: May 19, 2021· Updated: Jul 9, 2026

9.8
CVSS v3.1

Official Description

BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).

NVD Source

Technical Analysis

CVE-2017-17674 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.8.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

bmc1 product(s)
remedy mid-tier
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (4)

Quick Facts

CVE IDCVE-2017-17674
CVSS Score9.8 / 10
SeverityCRITICAL
WeaknessCWE-918
CISA KEVNo
Affected1 vendor(s)
PublishedMay 19, 2021

Related CVEs (CWE-918)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2017-17674 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.